Filter
1775
Filtered Results: 1775
Text search:
drug
registration
Featured
Recommendations
140
New Publications
553
Language
Document type
No document type
1108
Studies & Reports
245
Guidelines
203
Manuals
89
Strategic & Response Plan
77
Training Material
18
Fact sheets
16
Situation Updates
10
Resource Platforms
6
Brochures
2
Infographics
1
Countries / Regions
India
168
Kenya
63
Uganda
49
Global
48
Ethiopia
45
Tanzania
44
South Africa
42
Sierra Leone
40
Nigeria
40
Bangladesh
39
Ghana
38
Nepal
37
Malawi
34
Western and Central Europe
34
Namibia
31
Myanmar / Burma
31
Liberia
30
Africa
28
Rwanda
26
Ukraine
24
Zambia
22
Latin America and the Carribbean
20
Eastern Europe
19
Zimbabwe
17
Botswana
17
Cambodia
16
Philippines
15
South–East Asia Region
15
Lesotho
14
Asia
13
Indonesia
11
Syria
9
Congo, Democratic Republic of
8
Mozambique
7
Eswatini/ Swaziland
7
West and Central Africa
6
Russia
6
Colombia
5
East and Southern Africa
5
Brazil
5
Pakistan
5
Tajikistan
4
Timor Leste/ East Timor
4
Benin
4
Albania
4
Senegal
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Sri Lanka
4
Georgia
4
South Sudan
4
Cameroon
3
Haiti
3
Venezuela
3
Western Pacific Region
3
Argentina
3
Moldova
3
Sudan
3
Bhutan
3
Iraq
3
North Macedonia
2
Thailand
2
China
2
Chile
2
Iran
2
Laos
2
Burkina Faso
2
Afghanistan
2
Armenia
2
Jordan
2
Germany
2
Paraguay
2
North America
2
Uruguay
2
United Kingdom
2
Bolivia
2
Vietnam
2
Papua New Guinea
2
Angola
2
Libya
2
North Korea
1
Australia
1
Gambia
1
Kazakhstan
1
Fiji
1
Kyrgyzstan
1
Uzbekistan
1
Peru
1
Malaysia
1
Morocco
1
Bulgaria
1
Guinea
1
Italy
1
USA
1
Guinea-Bissau
1
Lithuania
1
Ireland
1
Saudi Arabia
1
Turkmenistan
1
Denmark
1
Maldives
1
Tunisia
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Greece
1
Central African Republic
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
891
Clinical Guidelines
126
Public Health
81
Key Resources
48
Women & Child Health
45
Pharmacy & Technologies
35
Capacity Building
22
Toolboxes
TB
196
HIV
172
Mental Health
80
AMR
80
Pharmacy
76
NTDs
56
COVID-19
53
NCDs
35
Caregiver
34
Malaria
34
Conflict
27
Refugee
23
Global Health Education
18
Rapid Response
17
Disability
16
Ebola & Marburg
13
Health Financing Toolbox
9
Planetary Health
8
Specific Hazards
7
Natural Hazards
7
2.0 Rapid Response
5
Polio
5
Zika
4
Cholera
2
Social Ethics
2
PLoS Negl Trop Dis 16(11): e0010908. https://doi.org/10.1371/journal.pntd.0010908
The aim of the meeting was to broaden the network’s initiatives. Preliminary work involved integrating laboratory testing for skin NTDs other than Buruli ulcer, such as cutaneous leishmaniasis, mycetoma, leprosy and yaws, while extending the network’s reach to encompass additional laboratories.
Version 2, January 2016
The primary purpose of this document is to provide 3MDG stakeholders with some essential information on the MNCH core-indicators for 3MDG, which were derived from the 3MDG Logical Framework, Data Dictionary for Health Service Indicators (2014 June, DoPH, MoH), A ... (MEASURE Evaluation, September 2005) and Monitoring Emergency Obstetric Care (WHO/UNICEF/UNFPA/AMDD). Partners are strongly encouraged to integrate the MNCH indicators into their ongoing monitoring and evaluation (M&E) activities.
These indicators are designed to help Partners assess the current state of their activities, their progress towards achieving their targets, and contribution towards the national response. This guideline is designed to improve the quality and consistency of data collected at the township level, which will enhance the accuracy of conclusions drawn when the data are aggregated.
The primary purpose of this document is to provide 3MDG stakeholders with some essential information on the MNCH core-indicators for 3MDG, which were derived from the 3MDG Logical Framework, Data Dictionary for Health Service Indicators (2014 June, DoPH, MoH), A ... (MEASURE Evaluation, September 2005) and Monitoring Emergency Obstetric Care (WHO/UNICEF/UNFPA/AMDD). Partners are strongly encouraged to integrate the MNCH indicators into their ongoing monitoring and evaluation (M&E) activities.
These indicators are designed to help Partners assess the current state of their activities, their progress towards achieving their targets, and contribution towards the national response. This guideline is designed to improve the quality and consistency of data collected at the township level, which will enhance the accuracy of conclusions drawn when the data are aggregated.
Trachoma is the leading infectious cause of blindness worldwide. In April 2023, it was a public health problem
in approximately 40 countries, with an estimated 116 million people at risk and 1.5 million people affected
by the late blinding stage of the disease (1). About 84% of those at risk of tr...
This annual report gives an overview of WHO lesotho Country office's undertakings and achievements in the context of an extraordinary health emergency. As we walk another mile this year, may we embrace all lessonst leanred in the previous year, learn from what did not work so well and take on new op...
The Integrated Management of Adolescent/Adult Illness (IMAI) approach
Policy note: Cambodia Health Systems in Transition.
The health system includes a mix of public and private providers. The use of private providers is much greater among the wealthy, while the use of informal-sector health providers is greater among the poor. Due to these circumstances there is ...
The health system includes a mix of public and private providers. The use of private providers is much greater among the wealthy, while the use of informal-sector health providers is greater among the poor. Due to these circumstances there is ...
Version 1.1
Department of Mental Health and Substance Abuse
Suicides take a high toll. Over 800 000 people die by suicide every year and it is the second leading cause of
death in 15-29-year-olds. Most suicides occur in low- and middle-income countries where resources
and services, if they do exist, are often scarce and limited for early identification, tr...
